Mad Money w/ Jim Cramer Mad Money w/ Jim Cramer 10/3/25
7 snips
Oct 3, 2025 Jim Cramer dives into how both skeptical professionals and enthusiastic retail investors are influencing market momentum. He discusses the impact of presidential drug pricing on pharmaceutical stocks. Cramer highlights SoFi's journey to profitability and explains the competitive landscape surrounding DraftKings. He addresses viewer calls about major stocks like MGM and Wingstop. Lastly, he argues for long-term investment in Apple instead of short-term trading.
AI Snips
Chapters
Books
Transcript
Episode notes
Retail FOMO Fuels Market Rally
- Individual retail investors and FOMO are powering the recent market rally despite professional skepticism.
- Professionals see bubbles everywhere but can't force prices down when amateurs keep buying.
Own Stocks, Don't Trade Them
- Own high-quality compounders like Apple and avoid frequent trading.
- Let gains compound over years and only act if something goes severely wrong.
SoFi's Rally Is Fundamentally Driven
- SoFi's recent rally is grounded in real growth: member counts and revenues have more than doubled.
- Profitability and consistent beats make its high multiples more tolerable given strong earnings growth.
